TACTILE SYSTEMS TECHNOLOGY INC

Tactile Systems Technology, Inc. (doing business as "Tactile Medical" since September 2013) is a medical technology company that develops and provides medical devices for the treatment of underserved chronic diseases. The company was originally incorporated in Minnesota on January 30, 1995, and reincorporated as a Delaware corporation on July 21, 2006. Tactile Medical focuses on advancing at-home care for chronic conditions, aiming to improve patient outcomes, quality of life, and control healthcare expenditures. Their therapeutic focus areas include: (1) vascular disease, specifically treating lymphedema and chronic venous insufficiency; (2) oncology, addressing lymphedema as a common consequence for cancer survivors; and (3) providing airway clearance therapy for individuals with chronic respiratory conditions. The company utilizes a scalable platform to deliver at-home healthcare solutions across the United States. For its lymphedema portfolio, Tactile Medical generally employs a direct-to-patient and -provider model. This involves obtaining patient referrals from clinicians, managing insurance claims for patients and clinicians, delivering solutions directly to patients, and training them on proper usage. This model facilitates direct engagement with both patients and clinicians, allowing the company to provide clinical evidence and education.